Skip to content
Screener

Trevi Therapeutics, Inc. TRVI Q2 2026 earnings

Reported August 6, 2026 · After market close

EPS-$0.11Miss by $0.00
EPS estimate-$0.11

Next report

Nov 12, 2026 (in 2 months)
EPS estimate-$0.13

FAQ

When did Trevi Therapeutics, Inc. report Q2 2026 earnings?
Trevi Therapeutics, Inc. (TRVI) reported Q2 2026 earnings on August 6, 2026 after market close.
What were Trevi Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Trevi Therapeutics, Inc. reported eps of $-0.11 for Q2 2026.
Did Trevi Therapeutics, Inc. beat estimates in Q2 2026?
EPS missed the consensus estimate of $-0.11 by $0.00.
How did Trevi Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 22.2% from $-0.09.
Where can I find Trevi Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-337974) and the 10-Q periodic report (0001193125-26-338023) directly on SEC EDGAR. The filing index links above go to sec.gov.